Bacterial vaginosis Clinical Trials

12 recruitingLast updated: June 19, 2026

There are 12 actively recruiting bacterial vaginosis clinical trials across 8 countries. Studies span Not Applicable, Phase 4, Early Phase 1, Phase 1, Phase 2. Top locations include Honolulu, Hawaii, United States, Irvine, California, United States, Jerusalem, Israel. Updated daily from ClinicalTrials.gov.


Bacterial vaginosis Trials at a Glance

12 actively recruiting trials for bacterial vaginosis are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Honolulu, Irvine, and Jerusalem. Lead sponsors running bacterial vaginosis studies include Douglas Kwon, Guy's and St Thomas' NHS Foundation Trust, and Cern Corporation.

Browse bacterial vaginosis trials by phase

Treatments under study

About Bacterial vaginosis Clinical Trials

Looking for clinical trials for Bacterial vaginosis? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacterial vaginosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacterial vaginosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study

Bacterial vaginosisCandida Vaginal
Guy's and St Thomas' NHS Foundation Trust114 enrolled2 locationsNCT05434104
Recruiting
Early Phase 1

Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome

Vulvovaginal candidiasisBacterial vaginosis
Queen's Medical Center22 enrolled1 locationNCT05753813
Recruiting

Prospective Data Bank Creation to Study Vaginal Conditions

VulvodyniaPreterm LaborBacterial vaginosis+1 more
Texas Tech University Health Sciences Center550 enrolled1 locationNCT01829204
Recruiting
Not Applicable

Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections

Bacterial vaginosisVaginal Candidiasis
Karo Pharma AB80 enrolled1 locationNCT07234786
Recruiting
Phase 1Phase 2

Vaginal Microbiota Transplant

Recurrent Bacterial Vaginosis
Douglas Kwon62 enrolled1 locationNCT04046900
Recruiting
Phase 4

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

Bacterial vaginosis
Peking University Shenzhen Hospital140 enrolled1 locationNCT04771728
Recruiting
Not Applicable

Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.

Bacterial vaginosis (BV)Recurrent Bacterial Vaginosis
S.I.I.T. Srl30 enrolled1 locationNCT06725888
Recruiting
Not Applicable

Clinical Protocol CERN Feasibility Study

Bacterial vaginosisFungal Vaginal Infections
Cern Corporation9 enrolled3 locationsNCT06933420
Recruiting
Phase 4

Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age

Bacterial vaginosis
I.M. Sechenov First Moscow State Medical University100 enrolled2 locationsNCT06458543
Recruiting
Not Applicable

The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation

Microbial ColonizationBacterial vaginosis
Hadassah Medical Organization100 enrolled1 locationNCT05963711
Recruiting
Not Applicable

Probiotic Efficacy in Postmenopausal Women with Bacterial Vaginosis

Bacterial vaginosis (BV)Menopause
Hasanuddin University12 enrolled1 locationNCT06659380
Recruiting
Not Applicable

Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis

Bacterial vaginosis
Zhujiang Hospital120 enrolled1 locationNCT06263465